Genomics USA

Genomics USA, Inc. was founded with the mission to innovate in the field of genetics and personalized medicine through advanced microarray technologies. The company focuses on Human Leukocyte Antigen (HLA) typing directly from raw biological samples, bypassing traditional DNA purification methods. Their core products include HLA Chip technology for applications in tissue transplantation, stem cell therapeutics, vaccine development, and personalized treatments for autoimmune diseases. Genomics USA aims to revolutionize healthcare by providing precise and efficient genetic analysis tools.

Notable figures associated with Genomics USA include a diverse team of experts and a scientific advisory board that guides their technological advancements. The company has successfully penetrated the growing market of genetics and personalized medicine, marked by the development of their unique microarray technology. Their key achievements include the creation of HLA typing solutions that enhance the accuracy and speed of genetic testing, thereby significantly impacting fields such as transplant compatibility and personalized healthcare.